Inhalation device options for the management of chronic obstructive pulmonary disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Postgraduate medicine

• Publication date

  2018-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00325481.2018.1399042PMID 29210318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire

  2017cited by this paper
• Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers

  2017cited by this paper
• How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?

  2017cited by this paper
• Adherence to COPD treatment: Myth and reality.

  2017cited by this paper
• Optimizing drug delivery in COPD: The role of inhaler devices.

  2017cited by this paper
• Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease

  2017cited by this paper
• Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop

  2017cited by this paper
• Inhaled Antibiotic Therapy for the Treatment of Upper Respiratory Tract Infections

  2017cited by this paper
• Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients

  2017cited by this paper
• Inhaled Drug Therapy 2016: The Year in Review

  2017cited by this paper
• Dry Powder Inhaler Delivery of Tobramycin in In Vitro Models of Tracheostomized Children

  2017cited by this paper
• Inhaler Technique in Asthma: How Does It Relate to Patients' Preferences and Attitudes Toward Their Inhalers?

  2017cited by this paper
• Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler

  2017cited by this paper
• Feasibility of Deploying Inhaler Sensors to Identify the Impacts of Environmental Triggers and Built Environment Factors on Asthma Short-Acting Bronchodilator Use

  2016cited by this paper
• Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients

  2016cited by this paper
• Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues

  2016cited by this paper
• Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.

  2016cited by this paper
• Use of a SmartPhone/Tablet-Based Bidirectional Telemedicine Disease Management Program Facilitates Early Detection and Treatment of COPD Exacerbation Symptoms

  2016cited by this paper
• Inhalation device requirements for patients' inhalation maneuvers.

  2016cited by this paper
• The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

  2016cited by this paper
• The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries

  2016cited by this paper
• Systematic Review of Errors in Inhaler Use: Has Patient Technique Improved Over Time?

  2016cited by this paper
• Evaluation of proficiency in using different inhaler devices among intern doctors

  2016cited by this paper
• Long Acting Nebulized Agents Decrease Readmissions in Patients With Suboptimal Peak Inspiratory Flow

  2016influential reference
• Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma.

  2015cited by this paper
• Inhaler Devices for Chronic Obstructive Pulmonary Disease: Insights from Patients and Healthcare Practitioners

  2015cited by this paper
• Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?

  2015cited by this paper
• Inhalation drug delivery devices: technology update

  2015influential reference
• The Inhalation Characteristics of Patients When They Use Different Dry Powder Inhalers

  2015influential reference
• Evaluating inhaler use technique in COPD patients

  2015cited by this paper
• Safety, Tolerability, and Plasma Exposure of Tiotropium Respimat® in Children and Adults with Cystic Fibrosis

  2015cited by this paper
• Dry powder inhalers and the right things to remember: a concept review

  2015cited by this paper
• Dry powder inhalers in COPD, lung inflammation and pulmonary infections

  2015cited by this paper
• Inhaler misuse in an older adult population.

  2015cited by this paper
• The importance of inhaler devices in the treatment of COPD

  2015cited by this paper
• Opportunities for inhaler device selection in elderly patients with asthma or COPD

  2015cited by this paper
• Dry powder inhalers and the right things to remember: a concept review

  2015cited by this paper
• Guidance on handheld inhalers in asthma and COPD guidelines.

  2014cited by this paper
• COPD: adherence to therapy

  2014influential reference
• Evaluation of Patient Preference and Willingness to Pay for Attributes of Maintenance Medication for Chronic Obstructive Pulmonary Disease (COPD)

  2014cited by this paper
• Clinical and economic impact of non-adherence in COPD: a systematic review.

  2014cited by this paper
• Tiotropium Respimat® Soft Mist™ Inhaler: A Review of Its Use in Chronic Obstructive Pulmonary Disease

  2014cited by this paper
• Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease

  2014cited by this paper
• Inhaler devices in asthma and COPD--an assessment of inhaler technique and patient preferences.

  2014cited by this paper
• Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence

  2014cited by this paper
• Inhaler reminders improve adherence with controller treatment in primary care patients with asthma.

  2014cited by this paper
• Considerations for managing chronic obstructive pulmonary disease in the elderly

  2013cited by this paper
• Prevalence and COPD Phenotype for a Suboptimal Peak Inspiratory Flow Rate against the Simulated Resistance of the Diskus® Dry Powder Inhaler

  2013cited by this paper
• Inhaler Devices for Patients with COPD

  2013cited by this paper
• Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation

  2013cited by this paper
• Inhaler competence in asthma: common errors, barriers to use and recommended solutions.

  2013cited by this paper
• The clinical and economic burden of chronic obstructive pulmonary disease in the USA

  2013cited by this paper
• Fine Particle Profile of Fluticasone Propionate/Formoterol Fumarate Versus Other Combination Products: the DIFFUSE Study

  2013cited by this paper
• Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach.

  2013cited by this paper
• The Role of Nebulized Therapy in the Management of COPD: Evidence and Recommendations

  2012cited by this paper
• The Genuair® inhaler: a novel, multidose dry powder inhaler

  2012cited by this paper
• Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting

  2012influential reference
• Physicians' Knowledge of Inhaler Devices and Inhalation Techniques Remains Poor in Spain

  2012cited by this paper
• Teaching the Use of Respiratory Inhalers to Hospitalized Patients with Asthma or COPD: a Randomized Trial

  2012cited by this paper
• Do we always need computed tomography to detect and treat parapneumonic pleural effusion?

  2012cited by this paper
• Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs.

  2011cited by this paper
• What the pulmonary specialist should know about the new inhalation therapies

  2011cited by this paper
• Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.

  2011cited by this paper
• Device type and real-world effectiveness of asthma combination therapy: an observational study.

  2011cited by this paper
• Inhaler mishandling remains common in real life and is associated with reduced disease control.

  2011cited by this paper
• The ADMIT series - issues in inhalation therapy. 6) Training tools for inhalation devices.

  2010cited by this paper
• Metered-Dose Inhaler Technique: The Effect of Two Educational Interventions Delivered in Community Pharmacy Over Time

  2010cited by this paper
• The ADMIT series - issues in inhalation therapy. 1) The goals of asthma treatment: can they be achieved?

  2010cited by this paper
• The ADMIT series--issues in inhalation therapy. 2. Improving technique and clinical effectiveness.

  2009cited by this paper
• New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy

  2009cited by this paper
• Not all asthma inhalers are the same: factors to consider when prescribing an inhaler.

  2009influential reference
• Knowledge of and technique for using inhalation devices among asthma patients and COPD patients.

  2009cited by this paper
• Patient adherence in COPD

  2008cited by this paper
• Medication adherence issues in patients treated for COPD

  2008cited by this paper
• Multidisciplinary care of the patient with chronic obstructive pulmonary disease.

  2008influential reference
• Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.

  2008cited by this paper
• Inhaled therapy in elderly COPD patients; time for re-evaluation?

  2007influential reference
• Inadequate Skill of Healthcare Professionals in Using Asthma Inhalation Devices

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?

  2007influential reference
• Enhancing COPD management in primary care settings.

  2007cited by this paper
• Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma

  2006cited by this paper
• Use of Respimat® Soft Mist™ Inhaler in COPD patients

  2006cited by this paper
• Evidence-Based Guidelines : Device Selection and Outcomes of Aerosol

  2005influential reference
• The Inhalation of Drugs: Advantages and Problems

  2005influential reference
• Problems With Inhaler Use: A Call for Improved Clinician and Patient Education

  2005cited by this paper
• Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey.

  2005influential reference
• Principles of Metered-Dose Inhaler Design

  2005influential reference
• The course of inhalation profiles during an exacerbation of obstructive lung disease.

  2004cited by this paper
• Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care

  2003cited by this paper
• Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects.

  2003cited by this paper
• Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age

  2002cited by this paper
• Aerosol therapy with valved holding chambers in young children: importance of the facemask seal.

  2001cited by this paper
• Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI.

  2000cited by this paper
• Respimat® (a New Soft Mist Inhaler) Delivering Fenoterol plus Ipratropium Bromide Provides Equivalent Bronchodilation at Half the Cumulative Dose Compared with a Conventional Metered Dose Inhaler in Asthmatic Patients

  2000cited by this paper
• Bronchodilator delivery with metered-dose inhaler during mechanical ventilation

  2000influential reference
• A Critical Comparison of the Dose Delivery Characteristics of Four Alternative Inhalation Devices Delivering Salbutamol: Pressurized Metered Dose Inhaler, Diskus Inhaler, Diskhaler Inhaler, and Turbuhaler Inhaler

  1999influential reference
• Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers.

  1997cited by this paper
• Competence thresholds for the use of inhalers in people with dementia.

  1997cited by this paper
• Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.

  1996cited by this paper

• AN OVERVIEW OF COPD: ITS ADVANCED THERAPEUTIC MANAGEMENT AND CHALLENGES FOR DRUG RELEASE AT THE TARGETED SITE

  2025cites this paper
• A Novel Inhalable Dry Powder to Trigger Delivery of Voriconazole for Effective Management of Pulmonary Aspergillosis

  2024cites this paper
• Unlocking Better Asthma Control: A Narrative Review of Adherence to Asthma Therapy and Innovative Monitoring Solutions

  2024cites this paper
• Education on Inhaler Technique by Pharmacists To Improve The Quality of Life of COPD Patients: A Systematic Review and Meta-Analysis

  2023cites this paper
• Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements

  2023cites this paper
• Assessment of Metered-Dose Inhalers with Spacer Technique among Postgraduate Trainees

  2023cites this paper
• Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation

  2022cites this paper
• Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home

  2021cites this paper
• A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in COPD.

  2021cites this paper
• Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis

  2021cites this paper
• In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®

  2020influential citation
• Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis

  2020cites this paper
• Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives

  2019cites this paper
• Physical stability of dry powder inhaler formulations

  2019cites this paper
• PPA_A_209532 1325..1334

  2019cites this paper
• Inhalation devices for asthma and COPD : A review of the literature

  2019cites this paper
• Patients’ usability of seven most used dry-powder inhalers in COPD

  2019cites this paper
• Formulation and Characterization of Pulmonary Drug Delivery Systems

  2019cites this paper
• New insights to improve treatment adherence in asthma and COPD

  2019cites this paper
• Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies.

  2019cites this paper
• Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease

  2018cites this paper
• An overview of glycopyrrolate/eFlow® CS in COPD

  2018influential citation